Medicinova Inc (MNOV): Shareholders' Equity
$41.59M
As of 2025-12-31
$37.27M
As of 2026-06-30
-16.0%
3-year compound annual growth
-10.2%
5-year compound annual growth
+2.4%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.59M | -20.8% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $52.50M | -15.8% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $62.38M | -11.2% | 2025-02-19, Balance as of period end |
| 2022-12-31 | $70.24M | -16.1% | 2024-02-15, Balance as of period end |
| 2021-12-31 | $83.68M | +17.3% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $71.33M | -4.8% | 2022-02-16, Balance as of period end |
| 2019-12-31 | $74.89M | +2.4% | 2021-02-19, Balance as of period end |
| 2018-12-31 | $73.11M | +89.2% | 2020-02-13, Balance as of period end |
| 2017-12-31 | $38.64M | +11.9% | 2019-02-13, Balance as of period end |
| 2016-12-31 | $34.53M | +5.4% | 2019-02-13, Balance as of period end |
| 2015-12-31 | $32.75M | +48.8% | 2018-02-13, Balance as of period end |
| 2014-12-31 | $22.01M | -13.4% | 2017-02-14, Balance as of period end |
| 2013-12-31 | $25.43M | +70.9% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $14.88M | -36.7% | 2014-03-27, Balance as of period end |
| 2011-12-31 | $23.50M | -4.9% | 2013-03-28, Balance as of period end |
| 2010-12-31 | $24.70M | -38.3% | 2013-03-28, Balance as of period end |
| 2009-12-31 | $40.01M | -16.7% | 2013-03-28, Balance as of period end |
| 2008-12-31 | $48.04M | -27.9% | 2013-03-28, Balance as of period end |
| 2007-12-31 | $66.61M | -34.0% | 2013-03-28, Balance as of period end |
| 2006-12-31 | $100.98M | -25.6% | 2013-03-28, Balance as of period end |
| 2005-12-31 | $135.71M | n/a | 2013-03-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Medicinova Inc (MNOV) | 2025-12-31 | $41.59M | -20.8% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.59M | +2.9% |
| America Great Health (AAGH) | 2025-06-30 | -$5.66M | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $70.12M | -11.3% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$6.30M | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.92M | -32.9% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $9.83M | -16.8% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $3.76M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $1.92M | -39.0% |
Compare MNOV, CANF, AAGH, SCNX side by side · Screen every company in Pharmaceutical Preparations ↗